Literature DB >> 9755422

Cryopreservation in human assisted reproduction is now routine for embryos but remains a research procedure for oocytes.

J Mandelbaum1, J Belaïsch-Allart, A M Junca, J M Antoine, M Plachot, S Alvarez, M O Alnot, J Salat-Baroux.   

Abstract

Human embryo cryopreservation represents an indispensable extension of in-vitro fertilization (IVF) programmes as long as they are based upon the recovery of a large number of oocytes. The most widely used procedures include the cryopreservation of human zygotes or embryos in early cleavage, using 1,2-propanediol and sucrose as cryoprotectants. Our results over a 10 year period (1986-1995) on 5032 thawed cycles involving 14 222 stored embryos make it possible to appraise the results and the contribution of embryo freezing to assisted reproduction. Embryos survived the freeze-thaw process in 73% of cases leading to 4590 transfers of 2.2 embryos (91% of thawed cycles). The clinical pregnancy rate per transfer was 16%, the live birth rate 12%, and the rate of babies born alive per transferred embryo was 6%. Embryo freezing monitored 10 years later produced an average of 8% of additional births. By then, 86% of stored embryos had been thawed for transfer to patients. Destruction or donation were required for only 8% of all frozen embryos and there was no news from the parental couple in relation to almost 6% of embryos. The fate of the vast majority of embryos was decided during the first 5 years of storage. Blastocyst cryopreservation is making new strides, thanks to co-culture systems and embryo selection. Micromanipulation procedures seem to have little impact on the outcome of embryo freezing. Human oocyte freezing is again clinically applied. Indeed, much of the concern about injuries to the oocyte structures through the freeze-thaw process do not seem to be justified, and the problems with frozen-thawed oocyte fertilization has been overcome using intracytoplasmic sperm injection (ICSI). As long as oocyte in-vitro maturation is not well controlled, better results will probably be obtained with mature oocyte cryopreservation. Emerging methods include the freezing of immature oocytes, follicles and ovarian tissue.

Entities:  

Mesh:

Year:  1998        PMID: 9755422     DOI: 10.1093/humrep/13.suppl_3.161

Source DB:  PubMed          Journal:  Hum Reprod        ISSN: 0268-1161            Impact factor:   6.918


  23 in total

1.  The influence of prefreeze growth rate and blastomere number on cryosurvival and subsequent implantation of human embryos.

Authors:  D H Edgar; H Jericho; H Bourne; J C McBain
Journal:  J Assist Reprod Genet       Date:  2001-03       Impact factor: 3.412

2.  The added value of embryo cryopreservation to cumulative ongoing pregnancy rates per IVF treatment: is cryopreservation worth the effort?

Authors:  D de Jong; M J C Eijkemans; N G M Beckers; R V Pruijsten; B C J M Fauser; N S Macklon
Journal:  J Assist Reprod Genet       Date:  2002-12       Impact factor: 3.412

3.  Correlation between embryological factors and pregnancy rate: development of an embryo score in a cryopreservation programme.

Authors:  Miquel Solé; Josep Santaló; Ignacio Rodríguez; Montse Boada; Buenaventura Coroleu; Pere N Barri; Anna Veiga
Journal:  J Assist Reprod Genet       Date:  2010-11-02       Impact factor: 3.412

4.  Emerging technologies in medical applications of minimum volume vitrification.

Authors:  Xiaohui Zhang; Paolo N Catalano; Umut Atakan Gurkan; Imran Khimji; Utkan Demirci
Journal:  Nanomedicine (Lond)       Date:  2011-08       Impact factor: 5.307

5.  Human cleavage-stage embryo vitrification is comparable to slow-rate cryopreservation in cycles of assisted reproduction.

Authors:  Martin Graham Wilding; Clemente Capobianco; Nadia Montanaro; Genc Kabili; Loredana Di Matteo; Enrico Fusco; Brian Dale
Journal:  J Assist Reprod Genet       Date:  2010-07-17       Impact factor: 3.412

6.  Cryopreservation of embryos, blastocysts, and pregnancy rates of blastocysts derived from frozen-thawed embryos and frozen-thawed blastocysts.

Authors:  K Pantos; K Stefanidis; K Pappas; P Kokkinopoulos; K Petroutsou; G Kokkali; D Stavrou; V Tzigounis
Journal:  J Assist Reprod Genet       Date:  2001-11       Impact factor: 3.412

7.  Oocyte vitrification: advances, progress and future goals.

Authors:  Ri-Cheng Chian; Yao Wang; Yi-Ran Li
Journal:  J Assist Reprod Genet       Date:  2014-01-30       Impact factor: 3.412

8.  Outcome Analysis of Day-3 Frozen Embryo Transfer v/s Fresh Embryo Transfer in Infertility: A Prospective Therapeutic Study in Indian Scenario.

Authors:  Neha Palo Chandel; Vidya V Bhat; B S Bhat; Sidharth S Chandel
Journal:  J Obstet Gynaecol India       Date:  2015-05-22

Review 9.  Human oocyte and ovarian tissue cryopreservation and its application.

Authors:  Tao Tao; Alfonso Del Valle
Journal:  J Assist Reprod Genet       Date:  2008-08-01       Impact factor: 3.412

10.  Simplified EM grid vitrification is a convenient and efficient method for mouse mature oocyte cryopreservation.

Authors:  Seok Hyun Kim; Seung-Yup Ku; Ki Cheong Sung; Moon Joo Kang; Sung Ah Kim; Hee Sun Kim; Sun Kyung Oh; Byung Chul Jee; Chang Suk Suh; Young Min Choi; Jung Gu Kim; Shin Yong Moon
Journal:  Yonsei Med J       Date:  2006-06-30       Impact factor: 2.759

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.